Why the study?
Does early life stress associated with underlying diseases reduce heart rate variability in children with short stature?
Does early life stress associated with underlying diseases reduce heart rate variability in children with short stature?
Reduced heart rate variability in children with short stature is driven by underlying conditions causing early life stress (such as congenital heart disease or SGA) rather than the short stature itself, indicating adverse autonomic imprinting and potential future cardiovascular risk.
Reduced HRV may indicate autonomic dysfunction in these children; hypothesis-generating for long-term cardiovascular risk after early stress.
INTRODUCTION: Early life stress is imprinting regulatory properties with life-long consequences. We investigated heart rate variability in a group of small children with height below the third percentile, who experienced an episode of early life stress due to heart failure or intra uterine growth retardation. These children appear to develop autonomic dysfunction in later life. RESULTS: Compared to the healthy control group heart rate variability (HRV) is reduced on average in a group of 101 children with short stature. Low HRV correlates to groups of children born small for gestational age (SGA), children with cardiac growth failure and children with congenital syndromes, but not to those with constitutional growth delay (CGD), who had normal HRV. Reduced HRV indicated by lower RMSSD and High Frequency (HF)-Power is indicating reduced vagal activity as a sign of autonomic imbalance. CONCLUSION: It is not short stature itself, but rather the underlying diseases that are the cause for reduced HRV in children with height below the third percentile. These high risk children-allocated in the groups with an adverse autonomic imprinting in utero or infancy (SGA, congenital heart disease and congenital syndromes)-have the highest risk for 'stress diseases' such as cardiovascular disease in later life. The incidence of attention deficit disorder is remarkably high in our group of short children.
No takes yet. Share an insight, caveat, or question.
Buchhorn et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: